Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Dana Cardin

5 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI1665

    06/01/2017

    A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5- Fluorouracil (5-FU)/Folinic Acid (FA) /Irinotecan (FOLFIRI)/Cetuximab with a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer

    Treatment

    ECOGGIS1513

    03/17/2017

    Randomized Phase II Study of 2nd Line FOLFIRI versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer

    Treatment

    ECOGGIA021501

    03/06/2017

    Preoperative Extended Chemotherapy vs. Chemotherapy plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas

    Treatment

    VICCGI1679

    03/03/2017

    A Pilot Study to Investigate the Safety and Efficacy of Avelumab Monotherapy in Patients with Advanced or Metastatic Adenocarcinoma of the Small Intestine

    Treatment

    VICCPHI1634

    08/30/2016

    A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01876 in Subjects with Advanced or Metastatic Solid Tumors


    Print this page for your doctor